LETO, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 4.704
EU - Europa 2.249
AS - Asia 1.011
SA - Sud America 172
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 8.193
Nazione #
US - Stati Uniti d'America 4.676
IT - Italia 726
CN - Cina 459
FI - Finlandia 399
SG - Singapore 357
UA - Ucraina 296
DE - Germania 216
BR - Brasile 153
IE - Irlanda 138
GB - Regno Unito 107
SE - Svezia 92
RU - Federazione Russa 83
FR - Francia 57
IN - India 37
BE - Belgio 29
EG - Egitto 29
RO - Romania 29
TR - Turchia 29
IR - Iran 23
CI - Costa d'Avorio 19
HK - Hong Kong 16
KR - Corea 16
NL - Olanda 13
CA - Canada 12
JP - Giappone 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
AT - Austria 9
CH - Svizzera 9
MY - Malesia 8
MX - Messico 7
ES - Italia 6
PL - Polonia 6
TW - Taiwan 6
IQ - Iraq 5
JM - Giamaica 5
PH - Filippine 5
VE - Venezuela 5
AR - Argentina 4
BA - Bosnia-Erzegovina 4
RS - Serbia 4
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
LB - Libano 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ML - Mali 1
NP - Nepal 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SV - El Salvador 1
Totale 8.193
Città #
Chandler 572
Fairfield 523
Ashburn 413
Woodbridge 351
Ann Arbor 270
Wilmington 261
Singapore 256
Houston 230
Palermo 220
Seattle 204
Cambridge 201
Jacksonville 155
Dublin 138
Medford 126
Des Moines 96
Princeton 83
Altamura 68
Boardman 62
Nanjing 60
Lawrence 54
San Diego 49
Jinan 43
New York 43
Tulsa 40
Milan 39
The Dalles 36
Santa Clara 32
Beijing 31
Shenyang 31
Nanchang 30
Brussels 29
Dearborn 26
Helsinki 26
Council Bluffs 25
Changsha 23
Guangzhou 23
Ludwigshafen am Rhein 23
Hebei 22
Tianjin 20
Abidjan 19
Munich 18
Los Angeles 15
Bagheria 14
London 14
Ningbo 14
Kumar 13
Cairo 12
Izmir 12
Jiaxing 12
Saint Petersburg 12
Zhengzhou 12
Naples 11
Rome 10
Tehran 10
Washington 10
Auburn Hills 9
Hong Kong 9
Norwalk 9
San Mateo 9
São Paulo 9
Frankfurt am Main 8
Giza 8
Haikou 8
Kitzingen 8
Orange 8
San Paolo di Civitate 8
Seongnam 8
Tashkent 8
Falls Church 7
Hangzhou 7
Lanzhou 7
Lucca 7
Moscow 7
Redwood City 7
Verona 7
Bremen 6
Chennai 6
Fuzhou 6
Istanbul 6
Shanghai 6
Taiyuan 6
Chicago 5
Dallas 5
Düsseldorf 5
Kilburn 5
Kingston 5
Mumbai 5
Oppido Mamertina 5
Prague 5
Pune 5
Tokyo 5
Trapani 5
Altavilla Milicia 4
Ankara 4
Atlanta 4
Casteldaccia 4
Columbus 4
Edinburgh 4
Groningen 4
Guarulhos 4
Totale 5.423
Nome #
Effects of Oleuropein on colon cancer progression in vitro. A preliminary report 210
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 204
Vitamin D in cancer chemoprevention 203
Follistatin as potential therapeutic target in prostate cancer 196
3,5-DIIODO-L-THYRONINE-INDUCED MODIFICATION IN PITUITARY-THYROID AXIS IN RATS FED HIGH-FAT DIET. A PRELIMINARY REPORT 190
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 182
Cathepsin L in metastatic bone disease: therapeutic implications 178
Different Behaviour of Plasma Antioxidant Status after Red Wine Consumption in Subjects of the Same Sex: A Preliminary Report 175
Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats 165
The Role of Vitamin K in Bone Remodeling and Osteoporosis 162
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 160
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 158
Serum follistatin in patients with prostate cancer metastatic to the bone 153
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 150
Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity 150
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 149
On the role of cystatin C in cancer progression 146
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications 143
Current status and future directions in the treatment of bone metastases from breast cancer 137
Activin A and bone metastasis 136
Influence of quercetin and luteolin on the activity of the catalase: study ex vivo about erythrocytes in smokers and non-smokers 133
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 119
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracycline 115
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 113
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracyclines 112
Nutrition, obesity and hormones 112
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 109
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone 108
Effect of extra virgin olive oli phenols on HL60 cell lines sensitive and resistant to anthracyclines 105
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma 104
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread 103
Cathepsin L in normal and pathological bone reodeling 103
Adipokines in obesity and metabolic diseases 100
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 97
Cytotoxic effects of a crude extract of extra virgin olive oil on human HL60 cell lines sensitive and resistant with MDR phenotype 97
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 96
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 95
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 95
Studio del pattern di distribuzione dell'Activina A nel siero di pazienti con metastasi ossee da carcinoma prostatico in trattamento con acido zoledronico 94
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 92
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 92
Cytotoxic effects of polyphenols from waste-water of extra virgin olive oil on human HL60 and K562 cell lines. 91
Modulating activity of dietary flavonols and flavan-3ols on the enzymes xanthina oxidase (XO) and mitochondrial superoxide dismutase (Mn-SOD) 91
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer 88
Induction of differentiation by phenols crude extract of extravirgin olive oil on tumor cell lines sensitive and resistatnt to antitumor agents 86
Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases 86
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 84
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 83
Effects of phenols of extra virgin olive oil on HL60 cell lines sensitive and reristant to anthracyclines 83
The potential of cystatin C as a predictive biomarker in breast cancer 82
ERYTHROCYTE CATALASE ACTIVITY IN EVER-SMOKERS AND NO-SMOKERS HEALTHY SUBJECTS: INFLUENCE OF FLAVONOIDS (QUERCETIN AND LUTEOLIN) 80
Influence of flavonoids on the transmembrane electron transport:study ex-vivo 79
Activin a and matrix metalloproteinase-2 and -9 blood levels as gauges of bone metastatic spread. In: Tumor microenvironment:Heterotypic interactions. 77
Lysosomal alterations in heart and liver of mice treated with doxorubicin 77
Cathepsin D content in colorectal cancer 77
Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A 77
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma 76
Selenium and Autoimmune Thyroiditis 76
Bioactive effects of citrus flavonoids and role in the prevention of atherosclerosis and cancer 73
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy 72
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease 71
Acute myocardial effects of mitoxantrone in the rabbit 71
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters 68
Effects of phenols of extra vergin olive oil on Hl60 cell lines sensitive and resistant to anthracycline 67
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis 64
Induction of differentiation by phenols crude extract of extavirgin olive oil on tumor cell lines sensitive and resistant to anticancer drugs 63
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance 63
Effects of eztra virgin olive oil phenols on HL60 cell line sensitive and resistant to anthracycline. 61
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart 61
Cathepsin D in the malignant progression of neoplastic diseases 60
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors 60
null 59
Biological characterization of laryngeal squamous-cell carcinoma 59
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis 59
Clinical significance of Activin A serum levels in patients with primary osteoporosis: a preliminary report 58
Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications 57
Physyological role of t-PMET in erythrocytes redox homeostasis: influence of flavonoids 55
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice 54
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report 53
Effects of extra virgin olive oil phenols on HL60 cell lines sensitve and resistant to anthracycline 48
null 47
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications 47
Characterization of the metastatic properties of two methylcholantrene-induced fibrosarcoma in mice 43
Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells 41
Tumor markers in urogynaecological tumors. 29
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 22
Nutrition, obesity and hormones 19
LIVELLI CIRCOLANTI DI ACTIVINA A IN PAZIENTI CON OSTEOPOROSI PRIMITIVA O METASTASI OSSEE DA CARCINOMA MAMMARIO 19
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 15
null 3
Totale 8.575
Categoria #
all - tutte 33.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020312 0 0 0 0 0 0 0 0 0 72 185 55
2020/20211.324 33 68 46 431 150 38 69 53 136 101 87 112
2021/20221.026 50 230 9 47 40 39 41 55 140 150 41 184
2022/20231.432 150 238 53 176 130 257 84 111 143 11 45 34
2023/2024735 34 96 49 55 63 119 56 66 29 38 33 97
2024/20251.060 37 80 98 195 74 75 113 116 100 172 0 0
Totale 8.575